Skip to Main

Thomas Delano joined Boston Consulting Group as a visiting associate in 2012 and joined fulltime in 2013. He is a core member of the Health Care practice and works with biopharma clients on R&D topics, digital transformation, and investor strategy. He has also conducted several large transformations and PMIs with health care clients.

Thomas also has experience in global health, particularly regarding access to medicines and regulatory harmonization. He leads Pride@BCG for the Europe, Middle East, and South America region.

AREAS OF EXPERTISE

EDUCATION

  • Diplôme d'Ingénieur, Ecole Centrale Paris
  • MSc, actuary sciences, Paris Dauphine University.

Publications and Videos

Impact in 60: Reimagining the Practice of Medicine Through Data and AI

Working with BCG, pharmaceutical giant Sanofi built a digital platform that optimizes the experience of patients and health care professionals alike.

COVID-19 Opens a New Era for Real-World Evidence in Pharma-rectangle.jpg

COVID-19 Opens a New Era for Real-World Evidence in Pharma

To capture the opportunities, companies must build a fit-for-purpose strategy while proactively helping to shape the regulatory environment.